Molecular interactions between telomerase and the tumor suppressor protein p53 in vitro

被引:71
作者
Li, H [1 ]
Cao, Y [1 ]
Berndt, MC [1 ]
Funder, JW [1 ]
Liu, JP [1 ]
机构
[1] Baker Med Res Inst, Mol Signalling Lab, Prahran, Vic 3181, Australia
基金
英国医学研究理事会;
关键词
telomerase reverse transcriptase (TERT); telomerase-associated protein 1 (TEP1); p53; telomerase inhibitory polypeptide 1 (TEIPP1); breast cancer cells;
D O I
10.1038/sj.onc.1203061
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The telomere DNA polymerase (telomerase) and the tumor suppressor protein p53 are frequently associated with human cancers, and activation of telomerase and inactivation of p53 involved in cancer cell immortalization. In this report, we demonstrate a direct interaction of telomerase with p53 in the nuclear lysates of human breast cancer cells, and with recombinant human p53, by affinity chromatography and immunoprecipitation. On activity criteria, the interaction is between the carboxyl-terminal region of p53 and a region close to the amino-terminus of human telomerase-associated protein 1 (hTEP1). Incubation of recombinant p53 with nuclear telomerase extracts results in inhibition of telomerase activity, with the C-terminal region of p53 being essential for inhibition. This effect is not mediated by binding to telomerase substrate DNA, but requires the region near the N-terminus of hTEP1, in that a synthetic peptide derived from this region of hTEP1 similarly inhibits telomerase activity. Together, these in vitro interactions between telomerase and p53 suggest that the activity of telomerase may be regulated by p53, downregulation of which in turn would favor up-regulation of telomerase activity in cancer cell development.
引用
收藏
页码:6785 / 6794
页数:10
相关论文
共 50 条
  • [1] Molecular interactions between telomerase and the tumor suppressor protein p53 in vitro
    He Li
    Ying Cao
    Michael C Berndt
    John W Funder
    Jun-Ping Liu
    Oncogene, 1999, 18 : 6785 - 6794
  • [2] Interactions between the tumor suppressor p53 and immune responses
    Menendez, Daniel
    Shatz, Maria
    Resnick, Michael A.
    CURRENT OPINION IN ONCOLOGY, 2013, 25 (01) : 85 - 92
  • [3] Molecular Architecture of Tumor Suppressor p53
    Viadiu, Hector
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2008, 8 (15) : 1327 - 1334
  • [4] Activation of the p53 tumor suppressor protein
    Vousden, KH
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2002, 1602 (01): : 47 - 59
  • [5] The tumor suppressor protein p53 and the ferroptosis network
    Kang, Rui
    Kroemer, Guido
    Tang, Daolin
    FREE RADICAL BIOLOGY AND MEDICINE, 2019, 133 : 162 - 168
  • [6] Interaction of metallothionein with tumor suppressor p53 protein
    Ostrakhovitch, EA
    Olsson, PE
    Jiang, S
    Cherian, MG
    FEBS LETTERS, 2006, 580 (05): : 1235 - 1238
  • [7] Tumor suppressor protein p53 isoform dynamics
    Caballero, Fernando E.
    Thayer, Kelly M.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2024, 42 : 6 - 6
  • [8] The Role of Tumor Suppressor p53 Protein in HIV-Host Cell Interactions
    Bakhanashvili, Mary
    CELLS, 2024, 13 (18)
  • [9] TIP30 Directly Binds p53 Tumor Suppressor Protein In Vitro
    Lee, Si-Hyung
    Ju, Sung-Kyu
    Lee, Tae-Young
    Huh, Sung-Ho
    Han, Kyou-Hoon
    MOLECULES AND CELLS, 2012, 34 (05) : 495 - 500
  • [10] Cancer Chemoprevention by Resveratrol: The p53 Tumor Suppressor Protein as a Promising Molecular Target
    Ferraz da Costa, Danielly C.
    Fialho, Eliane
    Silva, Jerson L.
    MOLECULES, 2017, 22 (06):